Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis

被引:28
作者
Dang, Lucy J. [1 ,3 ]
Lubel, John S. [2 ,3 ]
Gunatheesan, Shyamalar [1 ]
Hosking, Patrick [4 ]
Su, John [1 ,3 ,5 ]
机构
[1] Monash Univ, Dept Dermatol, Melbourne, Vic 3004, Australia
[2] Monash Univ, Box Hill Hosp, Melbourne, Vic 3004, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic 3004, Australia
[4] Univ Melbourne, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
关键词
adverse drug reaction; dermatology; gastroenterology; hepatitis; psoriasis; THERAPY; AUTOANTIBODIES; ARTHRITIS;
D O I
10.1111/ajd.12054
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We describe a case of previously unreported autoimmune hepatitis and lupus-like syndrome induced by infliximab treatment for chronic plaque psoriasis. The condition resolved after withdrawal of infliximab, with the liver injury having been reversed and minimal periportal fibrosis. In a two-part discussion we review the current literature on the pharmacology of infliximab and provide recommendations for management of infliximab side effects.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 20 条
[1]   Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus [J].
Aringer, Martin ;
Steiner, Guenter ;
Graninger, Winfried B. ;
Hoefler, Elisabeth ;
Steiner, Carl W. ;
Smolen, Josef S. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (01) :274-279
[2]   Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity [J].
Bassukas, I. D. ;
Hyphantis, T. ;
Gamvroulia, C. ;
Gaitanis, G. ;
Mavreas, V. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (02) :257-258
[3]  
Centocor, 2004, IMP DRUG WARN
[4]   Autoimmune hepatitis associated with infliximab in a patient with palmoplantar pustular psoriaisis [J].
Fairhurst, D. A. ;
Sheehan-Dare, R. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (03) :422-422
[5]   Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study [J].
Ferraro-Peyret, C ;
Coury, F ;
Tebib, JG ;
Bienvenu, J ;
Fabien, N .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (06) :R535-R543
[6]  
Goujon Catherine, 2010, J Am Acad Dermatol, V63, pe43, DOI 10.1016/j.jaad.2009.02.029
[7]   Simplified criteria for the diagnosis of autoimmune hepatitis [J].
Hennes, Elke M. ;
Zeniya, Mikio ;
Czaja, Albert. J. ;
Pares, Albert ;
Dalekos, George N. ;
Krawitt, Edward L. ;
Bittencourt, Paulo L. ;
Porta, Gilda ;
Boberg, Kirsten M. ;
Hofer, Harald ;
Bianchi, Francesco B. ;
Shibata, Minoru ;
Schramm, Christoph ;
de Torres, Barbara Eisenmann ;
Galle, Peter R. ;
McFarlane, Ian ;
Dienes, Hans-Peter ;
Lohse, Ansgar W. .
HEPATOLOGY, 2008, 48 (01) :169-176
[8]   Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction [J].
Hoffmann, J. H. O. ;
Hartmann, M. ;
Enk, A. H. ;
Hadaschik, E. N. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) :1355-1358
[9]   Opportunistic autoimmune disorders From immunotherapy to immune dysregulation [J].
Kong, Yi-chi M. ;
Wei, Wei-Zen ;
Tomer, Yaron .
YEAR IN IMMUNOLOGY 2, 2010, 1183 :222-236
[10]   Review and expert opinion on prevention and treatment of infliximab-related infusion reactions [J].
Lecluse, L. L. A. ;
Piskin, G. ;
Mekkes, J. R. ;
Bos, J. D. ;
de Rie, M. A. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (03) :527-536